Chunkyu Ko

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Hepatitis B Virus

Drug Administration

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte Hedskog, Christoph D Spinner, Ulrike Protzer, Dieter Hoffmann, Chunkyu Ko, Robert L Gottlieb, Medhat Askar, Meta Roestenberg, Jutte J C de Vries, Ellen C Carbo, Ross Martin, Jiani Li, Dong Han, Lauren Rodriguez, Aiyappa Parvangada, Jason K Perry, Ricard Ferrer, Andres Anton, Cristina Andrés, Vanessa Casares, Huldrych F Gunthard, Michael Huber, Grace A McComsey, Navid Sadri, Judith A Aberg, Harm van Bakel, Danielle P Porter
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses 16 (4) (2024)
Charlotte Hedskog, Christoph D Spinner, Ulrike Protzer, Dieter Hoffmann, Chunkyu Ko, Robert L Gottlieb, Medhat Askar, Meta Roestenberg, Jutte J C de Vries, Ellen C Carbo, Ross Martin, Jiani Li, Dong Han, Lauren Rodriguez, Aiyappa Parvangada, Jason K Perry, Ricard Ferrer, Andres Anton, Cristina Andrés, Vanessa Casares, Huldrych F Gunthard, Michael Huber, Grace A McComsey, Navid Sadri, Judith A Aberg, Harm van Bakel, Danielle P Porter
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses 16 (4) (2024)
Charlotte Hedskog, Christoph D Spinner, Ulrike Protzer, Dieter Hoffmann, Chunkyu Ko, Robert L Gottlieb, Medhat Askar, Meta Roestenberg, Jutte J C de Vries, Ellen C Carbo, Ross Martin, Jiani Li, Dong Han, Lauren Rodriguez, Aiyappa Parvangada, Jason K Perry, Ricard Ferrer, Andres Anton, Cristina Andrés, Vanessa Casares, Huldrych F Gunthard, Michael Huber, Grace A McComsey, Navid Sadri, Judith A Aberg, Harm van Bakel, Danielle P Porter
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses 16 (4) (2024)
Charlotte Hedskog, Christoph D Spinner, Ulrike Protzer, Dieter Hoffmann, Chunkyu Ko, Robert L Gottlieb, Medhat Askar, Meta Roestenberg, Jutte J C de Vries, Ellen C Carbo, Ross Martin, Jiani Li, Dong Han, Lauren Rodriguez, Aiyappa Parvangada, Jason K Perry, Ricard Ferrer, Andres Anton, Cristina Andrés, Vanessa Casares, Huldrych F Gunthard, Michael Huber, Grace A McComsey, Navid Sadri, Judith A Aberg, Harm van Bakel, Danielle P Porter
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses 16 (4) (2024)
Lena Allweiss, Barbara Testoni, Mei Yu, Julie Lucifora, Chunkyu Ko, Bingqian Qu, Marc Lütgehetmann, Haitao Guo, Stephan Urban, Simon P Fletcher, Ulrike Protzer, Massimo Levrero, Fabien Zoulim, Maura Dandri
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure. Gut (2023)
Lena Allweiss, Barbara Testoni, Mei Yu, Julie Lucifora, Chunkyu Ko, Bingqian Qu, Marc Lütgehetmann, Haitao Guo, Stephan Urban, Simon P Fletcher, Ulrike Protzer, Massimo Levrero, Fabien Zoulim, Maura Dandri
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure. Gut (2023)
Hyejin Kim, Chunkyu Ko, Joo-Youn Lee, Meehyein Kim
Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy. Molecules (Basel, Switzerland) 26 (24) (2021)
Katrin Manske, Annika Schneider, Chunkyu Ko, Percy A Knolle, Katja Steiger, Ulrike Protzer, Dirk Wohlleber
In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity. Viruses 13 (11) (2021)